Geschreven door studenten die geslaagd zijn Direct beschikbaar na je betaling Online lezen of als PDF Verkeerd document? Gratis ruilen 4,6 TrustPilot
logo-home
Tentamen (uitwerkingen)

NR 507 Final Exam (2026) | Chamberlain Advanced Pathophysiology Actual Questions and Answe

Beoordeling
-
Verkocht
-
Pagina's
36
Cijfer
A+
Geüpload op
15-04-2026
Geschreven in
2025/2026

NR 507 Final Exam (2026) | Chamberlain Advanced Pathophysiology Actual Questions and Answer

Instelling
NR 507 ADVANCED PATHOPHYSIOLOGY
Vak
NR 507 ADVANCED PATHOPHYSIOLOGY

Voorbeeld van de inhoud

NR 507 Final Exam (2026) | Chamberlain
Advanced Pathophysiology Actual Questions
and Answers (PDF)|Latest Updated!!




NR 507 Final Exam – Advanced Pathophysiology (2026)

1–30: Cellular Biology, Genetics, & Environment

1. A patient has a mutation in the TP53 gene. Which cellular process is most directly
impaired?
A. DNA replication
B. Apoptosis
C. ATP synthesis
D. Phagocytosis

Answer: B. TP53 (p53) is a tumor suppressor that triggers apoptosis or cell cycle arrest in
response to DNA damage.

2. Which phase of the cell cycle is most susceptible to damage by chemotherapy that targets
DNA synthesis?
A. G1
B. S
C. G2
D. M

Answer: B. S phase is when DNA replication occurs.

3. A patient with cystic fibrosis has a defect in which type of transport?
A. Sodium channel

,B. Chloride channel (CFTR)
C. Calcium ATPase
D. Potassium leak channel

Answer: B. CFTR chloride channel dysfunction leads to thick secretions.

4. Which genetic disorder is associated with a trinucleotide repeat expansion on the HTT
gene?
A. Fragile X syndrome
B. Huntington disease
C. Myotonic dystrophy
D. Spinocerebellar ataxia

Answer: B. Huntington disease = CAG repeat in HTT.

5. A newborn has dysmorphic features, heart defect, and palmar crease. Karyotype shows
47,XX,+21. This is an example of:
A. Monosomy
B. Trisomy
C. Deletion
D. Translocation

Answer: B. Trisomy 21 (Down syndrome).

6. Which type of mutation results in a premature stop codon?
A. Missense
B. Nonsense
C. Silent
D. Frameshift

Answer: B. Nonsense = stop codon.

7. A patient with neurofibromatosis type 1 inherited one normal and one mutated NF1
allele. Loss of the normal allele in Schwann cells leads to tumor formation. This is an
example of:
A. Dominant negative
B. Loss of heterozygosity

,C. Haploinsufficiency
D. Genomic imprinting

Answer: B. Loss of heterozygosity (second hit) in a tumor suppressor gene.

8. Which cellular adaptation is reversible and involves an increase in cell size?
A. Hyperplasia
B. Hypertrophy
C. Metaplasia
D. Dysplasia

Answer: B. Hypertrophy (e.g., cardiac muscle due to hypertension).

9. Metaplasia is best described as:
A. Increased cell number
B. Replacement of one differentiated cell type with another
C. Disordered cell growth
D. Decreased cell size

Answer: B. Metaplasia (e.g., Barrett esophagus).

10. A 60-year-old smoker develops a lung tumor. Whole-exome sequencing reveals a
mutation in KRAS that leads to constitutive activation. This is a:
A. Tumor suppressor gene
B. Proto-oncogene
C. DNA repair gene
D. Apoptosis gene

Answer: B. KRAS is a proto-oncogene; mutation turns it into an oncogene.

11. Which of the following is characteristic of malignant tumors?
A. Well-defined capsule
B. Slow growth
C. Invasion and metastasis
D. Resembles normal tissue

Answer: C. Invasion and metastasis are key features of malignancy.

, 12. Which inheritance pattern requires both parents to be carriers and affects males and
females equally?
A. X-linked recessive
B. Autosomal dominant
C. Autosomal recessive
D. Mitochondrial

Answer: C. Autosomal recessive (e.g., cystic fibrosis).

13. A man with hemophilia A (X-linked recessive) has a daughter with a woman without
hemophilia. The daughter:
A. Will have hemophilia
B. Is an obligate carrier
C. Cannot pass the gene to her sons
D. Has a 50% chance of being a carrier

Answer: B. She inherits father’s X with mutation → obligate carrier.

14. Which term describes the percentage of individuals with a specific genotype who
express the associated phenotype?
A. Expressivity
B. Penetrance
C. Pleiotropy
D. Heterogeneity

Answer: B. Penetrance.

15. A 3-year-old with recurrent infections, eczema, and thrombocytopenia is suspected to
have:
A. DiGeorge syndrome
B. Wiskott-Aldrich syndrome
C. Severe combined immunodeficiency
D. Chronic granulomatous disease

Answer: B. Wiskott-Aldrich (X-linked, triad: infections, eczema, low platelets).

Geschreven voor

Instelling
NR 507 ADVANCED PATHOPHYSIOLOGY
Vak
NR 507 ADVANCED PATHOPHYSIOLOGY

Documentinformatie

Geüpload op
15 april 2026
Aantal pagina's
36
Geschreven in
2025/2026
Type
Tentamen (uitwerkingen)
Bevat
Vragen en antwoorden

Onderwerpen

$12.99
Krijg toegang tot het volledige document:

Verkeerd document? Gratis ruilen Binnen 14 dagen na aankoop en voor het downloaden kun je een ander document kiezen. Je kunt het bedrag gewoon opnieuw besteden.
Geschreven door studenten die geslaagd zijn
Direct beschikbaar na je betaling
Online lezen of als PDF

Maak kennis met de verkoper
Seller avatar
nbrian

Maak kennis met de verkoper

Seller avatar
nbrian Teachme2-tutor
Volgen Je moet ingelogd zijn om studenten of vakken te kunnen volgen
Verkocht
1
Lid sinds
1 maand
Aantal volgers
0
Documenten
128
Laatst verkocht
1 maand geleden

0.0

0 beoordelingen

5
0
4
0
3
0
2
0
1
0

Recent door jou bekeken

Waarom studenten kiezen voor Stuvia

Gemaakt door medestudenten, geverifieerd door reviews

Kwaliteit die je kunt vertrouwen: geschreven door studenten die slaagden en beoordeeld door anderen die dit document gebruikten.

Niet tevreden? Kies een ander document

Geen zorgen! Je kunt voor hetzelfde geld direct een ander document kiezen dat beter past bij wat je zoekt.

Betaal zoals je wilt, start meteen met leren

Geen abonnement, geen verplichtingen. Betaal zoals je gewend bent via iDeal of creditcard en download je PDF-document meteen.

Student with book image

“Gekocht, gedownload en geslaagd. Zo makkelijk kan het dus zijn.”

Alisha Student

Bezig met je bronvermelding?

Maak nauwkeurige citaten in APA, MLA en Harvard met onze gratis bronnengenerator.

Bezig met je bronvermelding?

Veelgestelde vragen